NEW YORK (GenomeWeb) – Immucor today announced a collaboration with Stanford University spinout Sirona Genomics focused on human leukocyte antigen typing using next-generation sequencing.

Immucor will provide development funding to Sirona to support the commercialization of its NGS-based HLA typing sample preparation and bioinformatics offerings. Immucor will retain an exclusive option to acquire Sirona, which was spun out of the Stanford Genome Technology Center.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.